Investment in healthcare technology assets has remained stable, both before and after the booming years of 2020 and 2021. This trend is linked in particular to the consolidation of a fragmented sector in which many smaller companies are struggling to provide global solutions and achieve the critical mass required to effectively penetrate the healthcare and life sciences markets.
Read the article by Marie-Claude Benoit in ActuIA with data from our European Health Tech Quarterly Report Q1 2024.